Wearable Activity Trackers and Physical Activity Levels Among Members of the Athens Medical Association in Greece.

Autor: Lampsas S; 3rd Department of Cardiology, Thoracic Diseases General Hospital Sotiria, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece., Marinos G; Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece., Lamprinos D; Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece., Theofilis P; 1st Department of Cardiology, Hippokration General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece., Zakynthinos GE; 3rd Department of Cardiology, Thoracic Diseases General Hospital Sotiria, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece., Gialamas I; 3rd Department of Cardiology, Thoracic Diseases General Hospital Sotiria, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece., Lysandrou A; 3rd Department of Cardiology, Thoracic Diseases General Hospital Sotiria, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece., Pililis S; 2nd Department of Internal Medicine, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece., Pliouta L; 2nd Department of Internal Medicine, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece., Tzioumi G; 2nd Department of Internal Medicine, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece., Anastasopoulou E; 3rd Department of Cardiology, Thoracic Diseases General Hospital Sotiria, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece., Lambadiari V; 2nd Department of Internal Medicine, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece., Oikonomou E; 3rd Department of Cardiology, Thoracic Diseases General Hospital Sotiria, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece., Siasos G; Cardiovascular Division, Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.

Publikováno v: Journal of cardiovascular development and disease [J Cardiovasc Dev Dis] 2024 Oct 21; Vol. 11 (10). Date of Electronic Publication: 2024 Oct 21.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clinical Outcomes Beyond 1L EGFR -TKI Progression in mNSCLC: Final Results of the Real-World Study 'LUNGFUL'.

Autor: Mountzios G; Fourth Oncology Department and Clinical Trials Unit, Henry Dunant Hospital Center, Athens, Greece; ioamoun@dunant.gr., Koumarianou A; Hematology-Oncology Unit, Fourth Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece., Linardou H; 4 Oncology Department & Comprehensive Clinical Trials Center, Metropolitan Hospital, Athens, Greece., Boutis A; First Department of Clinical Oncology, Theagenio Hospital, Thessaloniki, Greece., Mavroudis D; Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece., Samantas E; 2 Oncology Department, Metropolitan Hospital, Athens, Greece., Korantzis I; Oncology Department, 'Saint Luke' Private Hospital, Thessaloniki, Greece., Athanasiadis E; Department of Medical Oncology, Mitera Hospital, Athens, Greece., Fergadis EG; Medical Oncology Department, Metaxa Cancer Hospital, Piraeus, Greece., Lampaki S; Pulmonary Department, General Hospital 'G. Papanikolaou', Aristotle University of Thessaloniki, Thessaloniki, Greece., Georgoulias V; First Department of Medical Oncology, Metropolitan General, Athens, Greece., Baka S; Oncology Department, 'Interbalkan' European Medical Center, Thessaloniki, Greece., Karamouzis MV; Molecular Oncology Unit, Department of Biological Chemistry Medical School, Athens, Greece., Boukovinas I; BIOCLINIC of Thessaloniki, Thessaloniki, Greece., Andreadis C; Second Department of Clinical Oncology, Theagenio Hospital, Thessaloniki, Greece., Rapti A; Second Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Sotiria Hospital, Athens, Greece., Koulouris N; First Department of Respiratory Medicine, National & Kapodistrian University of Athens Medical School, 'SOTIRIA' Hospital for Chest Diseases, Athens, Greece., Pentheroudakis G; Department of Medical Oncology, Medical School University of Ioannina, Ioannina, Greece., Froudarakis ME; Department of Respiratory Medicine, Medical School of Alexandroupolis Democritus University of Thrace, Alexandroupolis, Greece., Somarakis A; Medical Affairs Department, AstraZeneca, Athens, Greece., Anastasopoulou E; Medical Affairs Department, AstraZeneca, Athens, Greece., Karadimou A; Medical Affairs Department, AstraZeneca, Athens, Greece., Papageorgiou F; Diagnostics Function Oncology, AstraZeneca, Athens, Greece., Paparepa Z; Clinical Operations, AstraZeneca, Athens, Greece., Nikolaou A; Medical Affairs Department, AstraZeneca, Athens, Greece., Papista C; Medical Affairs Department, AstraZeneca, Athens, Greece., Syrigos KN; Third Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Sotiria Hospital, Athens, Greece.

Publikováno v: Anticancer research [Anticancer Res] 2023 May; Vol. 43 (5), pp. 2243-2258.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.